Kyounggi-do, South Korea

Jin-Chel Kim

This inventor holds 1 USPTO granted patent. Top assignees: Korea Research Inst. of Chem. Tech., Samjin Pharmaceutical Co., Ltd.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin-Chel Kim. Retrieved from https://idiyas.com/inventor/jin-chel-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jin-Chel Kim

Introduction

Jin-Chel Kim is a notable inventor based in Kyounggi-do, South Korea. He has made significant contributions to the field of chemistry, particularly in the development of antiviral compounds. His work has implications for medical research and pharmaceutical applications.

Latest Patents

Jin-Chel Kim holds a patent for "Antiviral 2,4-pyrimidinedione derivatives and process for the." This innovation showcases his expertise in creating compounds that may help combat viral infections. He has 1 patent to his name, reflecting his focused contributions to the field.

Career Highlights

Throughout his career, Jin-Chel Kim has worked with esteemed organizations such as the Korea Research Institute of Chemical Technology and Samjin Pharmaceutical Co., Ltd. His experience in these institutions has allowed him to collaborate with other experts and advance his research.

Collaborations

Jin-Chel Kim has collaborated with notable colleagues, including Jong-Chan Son and Iii Young Lee. These partnerships have enriched his research and contributed to the development of innovative solutions in the pharmaceutical industry.

Conclusion

Jin-Chel Kim's work exemplifies the impact of dedicated research and innovation in the field of chemistry. His contributions continue to influence the development of antiviral medications and highlight the importance of collaboration in scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…